摘要
背景:腹主动脉瘤(AAA)是一种导致65岁以上老年人死亡的退行性疾病,活性氧自由基(Ros)增加和氧化应激在AAA发病中起着重要作用。实验模型显示主动脉组织中有多种促肾上腺皮质激素(OS)的来源:炎症、NAD(P)h或NOx活性增高、诱导型一氧化氮合酶(INOS)过度表达、内皮型一氧化氮合酶(ENOS)解偶联、血小板活化和血红蛋白释放。 目的:人类研究证实氧化应激和内皮功能障碍是ROS产生的重要来源,与AAA的发展有着密切的关系。因此,通过抗氧化剂减少氧化应激可以是限制AAA发展的好策略。本研究的目的是审查有利于或不支持这样的假设的文献数据。目前还没有证据表明,使用经典的低分子量抗氧化剂(维生素c和e,β-胡萝卜素)作为促肾上腺皮质激素治疗的靶点是有效的。然而,最近的流行病学数据显示,富含抗氧化多酚的水果饮食通过激活Keap 1/Nrf 2/ARE途径恢复内皮功能和刺激酶促抗氧化剂的能力而发挥着积极的作用,多酚类化合物可以成为减少人类AAA进展的一个有希望的治疗靶点。 结论:临床研究迫切需要证实多酚类物质在预防或限制AAA中的潜在有益作用。
关键词: 实验性和人腹主动脉瘤,内皮功能,氧化应激,抗氧化剂,多酚,预防。
图形摘要
Current Drug Targets
Title:Abdominal Aortic Aneurysm (AAA): Is There a Role for the Prevention and Therapy Using Antioxidants?
Volume: 19 Issue: 11
关键词: 实验性和人腹主动脉瘤,内皮功能,氧化应激,抗氧化剂,多酚,预防。
摘要: Background: Abdominal aortic aneurysm (AAA) is a degenerative disease that causes mortality in people aged > 65 years. Increased reactive oxygen species (ROS) and oxidative stress seem to play a pivotal role in AAA pathogenesis. Several sources of ROS have been identified in aortic tissues using experimental models: inflammation, increased activity of NAD(P)H or NOX, over-expression of inducible nitric oxide synthase (iNOS), uncoupled endothelial nitric oxide synthase (eNOS), platelets activation and iron release from hemoglobin.
Objectives: Human studies confirmed that oxidative stress and endothelial dysfunction, an important source of ROS production, were well associated with AAA development. Reducing oxidative stress by antioxidants can therefore be a good strategy for limiting AAA development. The objective of the present study is to review literature data favoring or not such a hypothesis. There is currently no evidence showing that strategies using classical low molecular weight antioxidants (vitamins C and E, β- carotene) as target for ROS is effective to reduce human AAA progression. However, recent epidemiological data have highlighted the positive role of a diet enriched in fruits which contain high amounts of antioxidant polyphenols. By their ability to restore endothelial function and also their capacity to stimulate enzymatic antioxidants through activation of the Keap1/Nrf2/ARE pathway, polyphenols can represent a promising treatment target for reducing human AAA progression.
Conclusion: Clinical studies are therefore urgently necessary to confirm the potential beneficial effect of polyphenols in preventing or limiting AAA.
Export Options
About this article
Cite this article as:
Abdominal Aortic Aneurysm (AAA): Is There a Role for the Prevention and Therapy Using Antioxidants?, Current Drug Targets 2018; 19 (11) . https://dx.doi.org/10.2174/1389450118666170918164601
DOI https://dx.doi.org/10.2174/1389450118666170918164601 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiovascular Magnetic Resonance Imaging: State of the Art
Current Cardiology Reviews Oxidative Stress: Meeting Multiple Targets in Pathogenesis of Vascular Endothelial Dysfunction
Current Drug Targets Computer Aided Systems for Diabetic Retinopathy Detection Using Digital Fundus Images: A Survey
Current Medical Imaging Modeling Loss of Microvascular Wall Homeostasis during Glycocalyx Deterioration and Hypertension that Impacts Plasma Filtration and Solute Exchange
Current Neurovascular Research Regulation and Function of Rankl in Arterial Calcification
Current Pharmaceutical Design Recent Patents Review in Three Dimensional Ultrasound Imaging
Recent Patents on Biomedical Engineering (Discontinued) Myocardial Infarction in Systemic Lupus Erythematosus – the Sex-Specific Risk Profile
Current Pharmaceutical Design Is the Use of Autologous Platelet-Rich Plasma Gels in Gynecologic, Cardiac, and General, Reconstructive Surgery Beneficial?
Current Pharmaceutical Biotechnology The Predictive Value of Lipid Markers in Vascular Disease
Current Pharmaceutical Design Maintaining Plasma Fibrinogen Levels and Fibrinogen Replacement Therapies for Treatment of Intracranial Hemorrhage
Current Drug Targets Current Status of Carotid Stenting
Current Vascular Pharmacology Tako-tsubo Cardiomyopathy: A Review of the Literature
Current Cardiology Reviews Visceral and Subcutaneous Adiposity: Are Both Potential Therapeutic Targets for Tackling the Metabolic Syndrome?
Current Pharmaceutical Design Experimental Model Considerations for the Study of Protein-Energy Malnutrition Co-Existing with Ischemic Brain Injury
Current Neurovascular Research Mechanisms of Intimal Hyperplasia Learned from a Murine Carotid Artery Ligation Model
Current Vascular Pharmacology Diagnosis of Surgically-Treatable Forms of Primary Aldosteronism
Current Hypertension Reviews The 9p21 Locus and its Potential Role in Atherosclerosis Susceptibility; Molecular Mechanisms and Clinical Implications
Current Pharmaceutical Design Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inverse Regulation of MMP-9 and MMP-2 in Long-Term Follow-up After Acute Coronary Syndrome: Lack of Correlation with Platelet and Endothelial Cell Activation Markers
Vascular Disease Prevention (Discontinued) Genetic Variability of Matrix Metalloproteinase Genes in Cardiovascular Disease
Current Topics in Medicinal Chemistry